IGHE and neoplasm: An anti-human IgE FITC-conjugated antibody was used to detect endogenous IgE and also following treatment with anti-tumour IgE (SF-25) to understand whether free IgE Fcε receptors were available for exogenous IgE to bind and, to crosslink these on the surface of macrophages [[26], [27], [28]].